These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8061732)

  • 1. Pathogenesis and treatment of neonatal and postnatal pulmonary hypertension.
    Abman SH
    Curr Opin Pediatr; 1994 Jun; 6(3):239-47. PubMed ID: 8061732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled nitric oxide for treatment of pulmonary artery hypertension in the newborn and infant.
    Roberts JD
    Crit Care Med; 1993 Sep; 21(9 Suppl):S374-6. PubMed ID: 8365236
    [No Abstract]   [Full Text] [Related]  

  • 3. [Inhaled nitric oxide: a physiologic treatment of persistent pulmonary arterial hypertension in the newborn].
    Thébaud B; Mercier JC
    Arch Pediatr; 1997 Oct; 4(10):988-1003. PubMed ID: 9436499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Echocardiographic outcome of infants treated as newborns with inhaled nitric oxide for severe hypoxemic respiratory failure.
    Torielli F; Fashaw LM; Knudson O; Kinsella J; Ivy D; Valdes-Cruz L; Rosenberg A
    J Pediatr; 2001 Mar; 138(3):349-54. PubMed ID: 11241041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pathophysiology of persistent pulmonary hypertension of the newborn and the role of inhaled nitric oxide therapy.
    Kinsella JP; Abman SH
    J Perinatol; 1996; 16(2 Pt 2 Su):S24-7. PubMed ID: 8732545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide therapy for persistent pulmonary hypertension of the newborn.
    Miller CL
    Neonatal Netw; 1995 Dec; 14(8):9-15. PubMed ID: 8552021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhaled nitric oxide as a selective pulmonary vasodilator in clinical anesthesia.
    Morris GN; Rich GF
    AANA J; 1997 Feb; 65(1):59-67. PubMed ID: 9223941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Considerations in the management of hypoxemic respiratory failure and persistent pulmonary hypertension in term and late preterm neonates.
    Lakshminrusimha S; Konduri GG; Steinhorn RH
    J Perinatol; 2016 Jun; 36 Suppl 2():S12-9. PubMed ID: 27225960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhaled nitric oxide: its effects on pulmonary circulation and airway smooth muscle cells.
    Rossaint R; Pison U; Gerlach H; Falke KJ
    Eur Heart J; 1993 Nov; 14 Suppl I():133-40. PubMed ID: 8293764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coordinated regulation of genes of the nitric oxide and endothelin pathways during the development of pulmonary hypertension in fetal lambs.
    Black SM; Johengen MJ; Soifer SJ
    Pediatr Res; 1998 Dec; 44(6):821-30. PubMed ID: 9853913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent pulmonary hypertension of the newborn. Role of nitric oxide and endothelin in pathophysiology and treatment.
    Steinhorn RH; Millard SL; Morin FC
    Clin Perinatol; 1995 Jun; 22(2):405-28. PubMed ID: 7671545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The fetal circulation, pathophysiology of hypoxemic respiratory failure and pulmonary hypertension in neonates, and the role of oxygen therapy.
    Lakshminrusimha S; Saugstad OD
    J Perinatol; 2016 Jun; 36 Suppl 2():S3-S11. PubMed ID: 27225963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nitric oxide inhalation in newborn infants with pulmonary hypertension].
    de Beaufort AJ; Slot HM; van Bel F
    Ned Tijdschr Geneeskd; 1998 Jan; 142(3):123-7. PubMed ID: 9557009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of iNO in the modulation of pulmonary vascular resistance.
    Bin-Nun A; Schreiber MD
    J Perinatol; 2008 Dec; 28 Suppl 3():S84-92. PubMed ID: 19057617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of nitric oxide, endothelin, and prostaglandins in the transition of the pulmonary circulation.
    Ziegler JW; Ivy DD; Kinsella JP; Abman SH
    Clin Perinatol; 1995 Jun; 22(2):387-403. PubMed ID: 7671544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous sildenafil lowers pulmonary vascular resistance in a model of neonatal pulmonary hypertension.
    Shekerdemian LS; Ravn HB; Penny DJ
    Am J Respir Crit Care Med; 2002 Apr; 165(8):1098-102. PubMed ID: 11956051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhaled nitric oxide for the treatment of pulmonary hypertension before and after cardiopulmonary bypass.
    Wessel DL
    Crit Care Med; 1993 Sep; 21(9 Suppl):S344-5. PubMed ID: 8395994
    [No Abstract]   [Full Text] [Related]  

  • 18. Pulmonary hypertension in the newborn- etiology and pathogenesis.
    Sankaran D; Lakshminrusimha S
    Semin Fetal Neonatal Med; 2022 Aug; 27(4):101381. PubMed ID: 35963740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent pulmonary hypertension of the newborn.
    Thérèse P
    Paediatr Respir Rev; 2006; 7 Suppl 1():S175-6. PubMed ID: 16798554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent pulmonary hypertension of the newborn.
    Steinhorn RH
    Acta Anaesthesiol Scand Suppl; 1997; 111():135-40. PubMed ID: 9420986
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.